Athersys (ATHX) Misses Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Athersys (ATHX) Misses Q1 EPS by 2c

Athersys Reports First Quarter 2019 Results

May 8, 2019 4:05 PM EDT

CLEVELAND, May 08, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2019.

Highlights of the first quarter of 2019 and recent events include:

Announced positive results from our exploratory clinical study of MultiStem® cell therapy for treatment of acute respiratory distress syndrome ("MUST-ARDS"), showing reduced mortality and greater ventilator-free and ICU-free days in patients with moderate to severe ARDS;The MUST-ARDS study has been selected for presentation at the American Thoracic Society International Conference on May 20, 2019;Our partner in... More